Internal Medicine, Hematology & Oncology · Winter Haven, FL
NPI
1811209380
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
325 1st St N
Winter Haven, FL, 33881
Phone (863) 293-1191
Groups this clinician bills Medicare through
Medicare paid, 2024
$4.0M
272,431 services
Medicare patients, 2024
421
Average age 77
Drug cost, 2024
$9.5M
1,914 prescriptions
Company payments, 2025
$2,596
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahmad El-Far was code J1439 (injection, ferric carboxymaltose, 1 mg), 63,000 times for 39 patients. In total Ahmad El-Far billed 272,431 services in 192 codes, and Medicare paid $4.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 63,000 | 39 | $0.88 | $55K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 16,100 | 43 | $6.43 | $103K |
| Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 15,140 | 20 | $5.75 | $87K |
| J0897 Injection, denosumab, 1 mg | Office | 6,480 | 20 | $20.35 | $132K |
| J1642 Injection, heparin sodium, (heparin lock flush), per 10 units | Office | 3,751 | 29 | $0.01 | $43.15 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,538 | 44 | $0.09 | $317 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 2,500 | 19 | $15.74 | $39K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,475 | 27 | $0.10 | $253 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 2,021 | 24 | $0.74 | $1,487 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,528 | 21 | $0.07 | $113 |
| 36415 Venipuncture Blood Collection | Office | 1,216 | 292 | $8.65 | $11K |
| 85025 Blood Count | Office | 1,151 | 289 | $7.61 | $8,759 |
| 96372 Injection Administration | Office | 916 | 79 | $10.66 | $9,761 |
| 99213 Office E&M - Established | Office | 719 | 310 | $63.00 | $45K |
| 96361 Intravenous Infusion, Hydration | Office | 681 | 102 | $9.12 | $6,213 |
By year: 2022 $1.9M for 220,377 services; 2023 $2.5M for 308,109 services; 2024 $4.0M for 272,431 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,216 | 292 | $8.65 | $11K |
| 85025 Blood Count | 1,151 | 289 | $7.61 | $8,759 |
| 80053 Clinical Chemistry | 648 | 265 | $10.34 | $6,699 |
| 83540 Clinical Chemistry | 431 | 240 | $6.34 | $2,733 |
| 82728 Clinical Chemistry | 429 | 238 | $13.36 | $5,731 |
| 84466 Clinical Chemistry | 424 | 236 | $12.50 | $5,300 |
| 82607 Clinical Chemistry | 300 | 190 | $14.78 | $4,434 |
| 83615 Clinical Chemistry | 288 | 146 | $5.92 | $1,705 |
| 82746 Clinical Chemistry | 283 | 187 | $14.41 | $4,078 |
| 82378 Clinical Chemistry | 141 | 63 | $18.58 | $2,620 |
Medicare prescription drug claims, 2024
In 2024, the drug Ahmad El-Far prescribed most often to Medicare patients was Prednisone, with 101 prescriptions and refills. In total Ahmad El-Far wrote 1,914 Medicare prescriptions that cost $9.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 101 | 120 | 50 | $351 |
| Ondansetron Hcl Generic | 85 | 90 | 54 | $1,620 |
| Anastrozole Generic | 71 | 165 | 25 | $1,464 |
| Lenalidomide Generic | 68 | 68 | Under 11 | $945K |
| Xtandi Enzalutamide | 63 | 63 | Under 11 | $785K |
| Procrit Epoetin Alfa | 61 | 61 | 12 | $267K |
| Eliquis Apixaban | 59 | 86 | 29 | $46K |
| Dexamethasone Generic | 59 | 76 | 33 | $702 |
| Abiraterone Acetate Generic | 59 | 61 | Under 11 | $119K |
| Erleada Apalutamide | 58 | 61 | 11 | $841K |
| Hydroxyurea Generic | 56 | 130 | 25 | $1,490 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 50 | 50 | 15 | $470 |
| Acyclovir Generic | 44 | 72 | 15 | $616 |
| Oxycodone Hcl Generic | 41 | 41 | 18 | $304 |
| Letrozole Generic | 40 | 78 | 11 | $795 |
Brand drugs: 809 claims; generic drugs: 1,105 claims; opioid claims: 148.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahmad El-Far $2,596 ($2,596 in general payments such as food, travel and fees) from 34 companies. The largest payer was Novartis Pharmaceuticals Corporation with $226.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 9 | $226 |
| Incyte Corporation INCY | 8 | $193 |
| Pfizer Inc. PFE | 9 | $189 |
| Lilly USA, LLC LLY | 4 | $177 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $169 |
| Daiichi Sankyo Inc. 4568.T | 7 | $153 |
| Celgene Corporation BMY | 4 | $115 |
| Merck Sharp & Dohme LLC MRK | 5 | $106 |
| Seagen Inc. PFE | 1 | $99.99 |
| Dendreon Pharmaceuticals LLC | 3 | $91.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.